Proudly Announcing the Launch of Risek Plus in Saudi Arabia

At Julphar, we recognize our responsibility as a key healthcare partner in Saudi Arabia, therefore, this launch marks an important milestone in our commitment to advancing gastroenterology care and improving patient outcomes across the Kingdom. Risek Plus designed to deliver reliable acid suppression, addressing key clinical challenges in GERD and related conditions. Its introduction adds meaningful value across the healthcare ecosystem.

As part of this launch, three scientific symposia were successfully held across the Kingdom, led by eminent experts in the field of gastroenterology. These scientific gatherings brought together healthcare professionals to:
 

• Discuss unmet needs in acid-related disorders.
• Review the scientific rationale behind Omeprazole–Sodium Bicarbonate combinations.
• Share real-world clinical experience and best practices.
• Reinforce evidence-based, patient-centric treatment decisions.

The launch of Risek Plus reflects our ongoing dedication to science, partnership, and patient care — and it is only the beginning of what we aim to deliver to the Saudi healthcare community.